# IL13 Signaling in Allergic Asthma

> **NCT05478824** · — · COMPLETED · sponsor: **Duke University** · enrollment: 28 (actual)

## Conditions studied

- Asthma, Allergic
- Asthma
- Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05478824
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-21
- **Primary completion:** 2025-11-11
- **Final completion:** 2025-11-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05478824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05478824, "IL13 Signaling in Allergic Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05478824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*